Scopio Labs
Founded Year
2015Stage
Series C | AliveTotal Raised
$73MLast Raised
$50M | 4 mos agoScopio Labs's Products & Differentiation
See Scopio Labs's products and how their products differentiate from alternatives and competitors
Scopio Labs Full Field Peripheral Blood Smear Application
Scopio are addressing a worldwide problem of the delayed diagnosis and treatment hampered by the lack of innovation in first-line laboratory testing and the manual process still being used in the review of PBS. The FF-PBS Application allows for scanning peripheral blood smears, creating high resolution images combined with powerful AI to automatically detect, classify and quantify the cells, enabling the hematopathologist to view up to 200 cells on a peripheral blood smear with significantly greater consistency, efficiency and speed, and true remote review capabilities. Thus, Scopio has created a complete digital transformation of cell morphology analysis which completely supplants or replaces the manual microscope. With a digital end-to-end solution and relevant workflow tools,Scopio allows for faster, more accurate diagnoses.
Subscribe to see more
We're on a mission to enable every organization to make smarter decisions about tech. Whether it's finding a new game-changing vendor or understanding a new market, it's easier, faster and smarter with CB Insights. All made possible by the smartest, hardest-working team in tech. Subscribe to see more.
Subscribe to see more
We're on a mission to enable every organization to make smarter decisions about tech. Whether it's finding a new game-changing vendor or understanding a new market, it's easier, faster and smarter with CB Insights. All made possible by the smartest, hardest-working team in tech. Subscribe to see more.
Subscribe to see more
We're on a mission to enable every organization to make smarter decisions about tech. Whether it's finding a new game-changing vendor or understanding a new market, it's easier, faster and smarter with CB Insights. All made possible by the smartest, hardest-working team in tech. Subscribe to see more.
Expert Collections containing Scopio Labs
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Scopio Labs is included in 5 Expert Collections, including Artificial Intelligence.
Artificial Intelligence
8,717 items
This collection includes startups selling AI SaaS, using AI algorithms to develop their core products, and those developing hardware to support AI workloads.
Medical Devices
11,368 items
Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.
Health Monitoring & Diagnostics
2,394 items
Companies developing or offering products that aid in the assessment, screening, diagnosis, or monitoring of a person's state of health/wellness. Excludes companies focused solely on fitness/sports performance
Digital Health
12,800 items
Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)
Health IT
7,900 items
Scopio Labs Patents
Scopio Labs has filed 13 patents.
The 3 most popular patent topics include:
- Microscopy
- Image processing
- Microscopes
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
10/26/2017 | 3/2/2021 | Microscopy, Image processing, Nanotechnology, Microscopes, Digital photography | Grant |
Application Date | 10/26/2017 |
|---|---|
Grant Date | 3/2/2021 |
Title | |
Related Topics | Microscopy, Image processing, Nanotechnology, Microscopes, Digital photography |
Status | Grant |
Latest Scopio Labs News
Feb 10, 2022
Scopio's powerful end-to-end solutions, tailored to specific microscopy workflows. Courtesy. Israeli digital microscopy company, Scopio Labs , secured a $50 million investment in Series C funding led by venture firms, OurCrowd, Aurum Ventures, Mizrahi-Tefahot Bank Invest, and Ilex Medical, the company announced on Tuesday. The company said it will use the new investment to double its employee roster and continue to expand its strategic partnerships and sales and enhance its software’s technological functions. Founded in 2015 by Itai Hayut and Erez Na’aman, Scopio Labs’ imaging platform uses computational photography and an AI-driven Decision Support System (DSS) to digitize, quantify, and analyze hematology and cytology cell samples with ultra-high resolution. This service makes identifying potential cell abnormalities easier and more precise, enabling hematopathologists to zoom in on the finest of details. In addition, Scopio Labs has built and integrated various AI and remote consultation solutions for large and small-scale labs and hospitals as a means of upgrading diagnostic processes and minimizing turnaround time. Other AI solutions including “bone marrow aspirates (BMA)” are currently in development. “Deep learning can analyze hundreds of times more healthcare data from a patient, supporting physician decisions and detecting conditions like cancers, anemias, and bleeding disorders, as well as infections and allergies,” said Scopio co-founder and CEO Itai Hayut. “But for us, it all begins with high-quality digital imaging data.” “In the 21st century, people shouldn’t be looking through microscopes, manually counting cells,” Hayut continued. “Scopio’s full-field imaging and AI platform means tens of thousands of cells in a single sample can be examined, counted and analyzed instantly and reviewed by a specialist regardless of location, leading to faster, easier and earlier detection and diagnosis of cancers and many other life-threatening medical conditions.” Scopio Labs’ imaging platform is now in use in major laboratories and medical centers worldwide, and its FDA-cleared Full-Field Peripheral Blood Smear (FF PBS) application, as well as its ScopioVet veterinary application, are in full commercial use throughout the US and Europe
Scopio Labs Web Traffic
Scopio Labs Rank
When was Scopio Labs founded?
Scopio Labs was founded in 2015.
Where is Scopio Labs's headquarters?
Scopio Labs's headquarters is located at Tel Aviv.
What is Scopio Labs's latest funding round?
Scopio Labs's latest funding round is Series C.
How much did Scopio Labs raise?
Scopio Labs raised a total of $73M.
Who are Scopio Labs's competitors?
Competitors of Scopio Labs include CellaVision.
What products does Scopio Labs offer?
Scopio Labs's products include Scopio Labs Full Field Peripheral Blood Smear Application and 4 more.
You May Also Like
SigTuple combines artificial intelligence, robotics and data science to build smart screening solutions, to make healthcare accurate, accessible and affordable. SigTuple is building a healthier India with quality healthcare, delivered by empowered providers, to ensure standardization and scalability of cutting-edge innovations in healthcare delivery.
VitruvianMD offers a digital platform that specializes in medical diagnosis services through artificial intelligence (AI) technology.
Noul (KOSDAQ: 376930) develops a portable device that uses image analysis combined with artificial intelligence to diagnose diseases from blood samples. Noul was founded in 2015 and is based in Yongin-si, South Korea.
CellaVision is a medical technology company that develops and sells its own systems for routine analysis of blood and other body fluids in health care services.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.